Which Patients Should We Follow up beyond 5 Years after Definitive Therapy for Localized Renal Cell Carcinoma?
Sang Hyub Lee, Hee Seo Son, Seok Cho, Sang Jin Kim, Dae Seon Yoo, Seok Ho Kang, Sung Yul Park, Jinsung Park, Sung-Goo Chang, Seung Hyun Jeon
Cancer Res Treat. 2015;47(3):489-494.   Published online 2014 Nov 17     DOI: https://doi.org/10.4143/crt.2014.013
Citations to this article as recorded by Crossref logo
Machine Learning Approach to Predict the Probability of Recurrence of Renal Cell Carcinoma After Surgery: Prediction Model Development Study
HyungMin Kim, Sun Jung Lee, So Jin Park, In Young Choi, Sung-Hoo Hong
JMIR Medical Informatics.2021; 9(3): e25635.     CrossRef
Risk‐adjusted proposal for >60 months follow up after surgical treatment of organ‐confined renal cell carcinoma according to life expectancy
Sebastian K Frees, Mohammed M Kamal, Sebastian Nestler, Patrick MF Levien, Samir Bidnur, Walburgis Brenner, Christian Thomas, Wolfgang Jaeger, Joachim W Thüroff, Frederik C Roos
International Journal of Urology.2019; 26(3): 385.     CrossRef
Partial nephrectomy versus ablative techniques for small renal masses: a systematic review and network meta-analysis
Johannes Uhlig, Arne Strauss, Gerta Rücker, Ali Seif Amir Hosseini, Joachim Lotz, Lutz Trojan, Hyun S. Kim, Annemarie Uhlig
European Radiology.2019; 29(3): 1293.     CrossRef